Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β
暂无分享,去创建一个
[1] A. Roses,et al. Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .
[2] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[3] David I. K. Martin,et al. microRNA-Mediated Messenger RNA Deadenylation Contributes to Translational Repression in Mammalian Cells , 2009, PloS one.
[4] N. Schonrock,et al. Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods? , 2008, Journal of Alzheimer's disease : JAD.
[5] S. Vatner,et al. Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes , 2009, Circulation research.
[6] Shibo Jiang,et al. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. , 2008, Genes & development.
[7] D. Selkoe,et al. Deciphering the genetic basis of Alzheimer's disease. , 2002, Annual review of genomics and human genetics.
[8] P. Day,et al. Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction. , 2004, Analytical biochemistry.
[9] Juan Nunez-Iglesias,et al. Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation , 2010, PloS one.
[10] J. Götz,et al. Functional Genomics meets neurodegenerative disorders Part I: Transcriptomic and proteomic technology , 2005, Progress in Neurobiology.
[11] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[12] J. Haines,et al. Fine mapping of the GLC1K juvenile primary open-angle glaucoma locus and exclusion of candidate genes , 2008, Molecular vision.
[13] Valérie Wilquet,et al. Amyloid-beta precursor protein processing in neurodegeneration , 2004, Current Opinion in Neurobiology.
[14] M. Guilhaus,et al. Aβ and human amylin share a common toxicity pathway via mitochondrial dysfunction , 2010, Proteomics.
[15] N. Rajewsky,et al. Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.
[16] T. Obinata,et al. Molecular cloning and characterization of neural activity‐related RING finger protein (NARF): a new member of the RBCC family is a candidate for the partner of myosin V , 2001, Journal of neurochemistry.
[17] David I. K. Martin,et al. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] W. Filipowicz,et al. Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.
[19] Jürgen Götz,et al. Functional Genomics meets neurodegenerative disorders Part II: Application and data integration , 2005, Progress in Neurobiology.
[20] L. Mucke,et al. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. , 2006, The Journal of clinical investigation.
[21] J. Ott,et al. Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer , 2010, Pharmacogenetics and genomics.
[22] B. Hemmings,et al. Altered levels of PP2A regulatory B/PR55 isoforms indicate role in neuronal differentiation , 2006, International Journal of Developmental Neuroscience.
[23] Guiliang Tang,et al. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. , 2010, The American journal of pathology.
[24] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[25] E. F. da Cruz e Silva,et al. Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease. , 2010, CNS & neurological disorders drug targets.
[26] Kenjiro Ono,et al. Structure–neurotoxicity relationships of amyloid β-protein oligomers , 2009, Proceedings of the National Academy of Sciences.
[27] Emmette R. Hutchison,et al. The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair , 2009, NeuroMolecular Medicine.
[28] Guiliang Tang,et al. The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 , 2008, The Journal of Neuroscience.
[29] C. Barbato,et al. MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons* , 2010, The Journal of Biological Chemistry.
[30] A. Salminen,et al. SIRT1: regulation of longevity via autophagy. , 2009, Cellular signalling.
[31] P. Nelson,et al. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. , 2010, Journal of Alzheimer's disease : JAD.
[32] A. Delacourte,et al. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.
[33] L. Mucke,et al. Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.
[34] L. Hood,et al. Massively Parallel Signature Sequencing and Bioinformatics Analysis Identifies Up-Regulation of TGFBI and SOX4 in Human Glioblastoma , 2010, PloS one.
[35] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[36] P. Puigserver,et al. Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.
[37] Amar Deep Sharma,et al. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues , 2010, Aging.
[38] I. Plante,et al. MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1* , 2009, Journal of Biological Chemistry.
[39] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[40] C. Tabin,et al. miRNA malfunction causes spinal motor neuron disease , 2010, Proceedings of the National Academy of Sciences.
[41] P. Gruss,et al. Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration , 2008, Proceedings of the National Academy of Sciences.
[42] Jürgen Götz,et al. Glial cells under physiologic and pathologic conditions. , 2002, Archives of neurology.
[43] S. Hébert,et al. Alterations of the microRNA network cause neurodegenerative disease , 2009, Trends in Neurosciences.
[44] Jun Wang,et al. Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction* , 2006, Journal of Biological Chemistry.
[45] R. Cappai,et al. An update on the toxicity of Aβ in Alzheimer’s disease , 2008, Neuropsychiatric disease and treatment.
[46] Thomas Preiss,et al. Methods to analyze microRNA-mediated control of mRNA translation. , 2007, Methods in Enzymology.
[47] Rie Teraoka,et al. A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.
[48] M. Yamakuchi,et al. miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.
[49] M. Siomi,et al. Posttranscriptional regulation of microRNA biogenesis in animals. , 2010, Molecular cell.
[50] A. Verkhratsky,et al. Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression , 2007, Journal of neurochemistry.
[51] L. Knudsen,et al. Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma , 2009, Leukemia and Lymphoma.
[52] T. Preiss,et al. Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β , 2010, PloS one.
[53] A. Delacourte,et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.